Strei Katherine 4
4 · Emergent BioSolutions Inc. · Filed Feb 26, 2021
Insider Transaction Report
Form 4
Strei Katherine
EVP, Chief HR Officer
Transactions
- Award
Common Stock
2021-02-24+2,674→ 30,655 total - Tax Payment
Common Stock
2021-02-24$93.49/sh−619$57,870→ 32,710 total - Tax Payment
Common Stock
2021-02-26$97.15/sh−649$63,050→ 32,061 total - Award
Employee Stock Options (Right to Buy)
2021-02-24$93.49/sh+10,696$999,969→ 10,696 totalExercise: $93.49Exp: 2028-02-23→ Common Stock (10,696 underlying) - Award
Common Stock
2021-02-24+2,674→ 33,329 total - Tax Payment
Common Stock
2021-02-26$97.15/sh−561$54,501→ 31,500 total
Footnotes (4)
- [F1]Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- [F2]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.
- [F3]Represents shares of common stock withheld to pay taxes.
- [F4]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.